6C42.4ICD-11 MMS 2026-01
Synthetic cannabinoid withdrawal
Description
Synthetic cannabinoid withdrawal is a clinically significant cluster of symptoms, behaviours and/or physiological features, varying in degree of severity and duration, that occurs upon cessation or reduction of use of synthetic cannabinoids in individuals who have developed Synthetic cannabinoid dependence or have used synthetic cannabinoids for a prolonged period or in large amounts. Presenting features of Synthetic cannabinoid withdrawal may include irritability, anger, aggression, shakiness, insomnia and disturbing dreams, restlessness, anxiety, depressed mood and appetite disturbance. In the early phase, Synthetic cannabinoid withdrawal may be accompanied by residual features of intoxication from the drug, such as paranoid ideation and auditory and visual hallucinations.
Index terms
- Synthetic cannabinoid withdrawal
Exclusions from above levels
Sibling codes
6C42.0– Episode of harmful use of synthetic cannabinoids6C42.1– Harmful pattern of use of synthetic cannabinoids6C42.2– Synthetic cannabinoid dependence6C42.3– Synthetic cannabinoid intoxication6C42.5– Synthetic cannabinoid-induced delirium6C42.6– Synthetic cannabinoid-induced psychotic disorder6C42.7– Certain specified synthetic cannabinoids-induced mental or behavioural disorders6C42.Y– Other specified disorders due to use of synthetic cannabinoids6C42.Z– Disorders due to use of synthetic cannabinoids, unspecified
Foundation entity
Synthetic cannabinoid withdrawal – http://id.who.int/icd/entity/397276103
Allowed postcoordination axes
Part of: 6C42: Disorders due to use of synthetic cannabinoids › 06: Mental, behavioural or neurodevelopmental disorders